Manuel Lobo

682 total citations
6 papers, 249 citations indexed

About

Manuel Lobo is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Manuel Lobo has authored 6 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Manuel Lobo's work include Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Cardiac Imaging and Diagnostics (2 papers). Manuel Lobo is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Cardiac Imaging and Diagnostics (2 papers). Manuel Lobo collaborates with scholars based in Spain and United States. Manuel Lobo's co-authors include Borja Ibáñez, Javier Sánchez‐Gonzalez, Rocío Villena-Gutiérrez, Valentı́n Fuster, Carlos Galán‐Arriola, Gonzalo Javier López, Eduardo Oliver, Antonio Molina, Claudia Pérez‐Martínez and Jean Paul Vilchez‐Tschischke and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Cardiovascular Research.

In The Last Decade

Manuel Lobo

6 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Lobo Spain 4 214 116 56 37 34 6 249
Gonzalo Javier López Spain 6 239 1.1× 125 1.1× 55 1.0× 37 1.0× 34 1.0× 7 275
Jean Paul Vilchez‐Tschischke Spain 9 269 1.3× 136 1.2× 48 0.9× 32 0.9× 42 1.2× 18 356
William O. Ntim United States 12 439 2.1× 252 2.2× 45 0.8× 39 1.1× 54 1.6× 18 533
Hasan Akkaya Türkiye 6 243 1.1× 45 0.4× 129 2.3× 20 0.5× 82 2.4× 14 273
Ariadna Domènech Spain 5 445 2.1× 97 0.8× 230 4.1× 27 0.7× 103 3.0× 10 486
Fiona Donovan United States 3 241 1.1× 120 1.0× 49 0.9× 19 0.5× 29 0.9× 6 261
A. Martínez Monzonís Spain 6 217 1.0× 68 0.6× 83 1.5× 7 0.2× 49 1.4× 25 261
Carlos Álvarez-Ortega Spain 3 185 0.9× 60 0.5× 81 1.4× 7 0.2× 41 1.2× 6 208
W. Mckenzie Australia 4 394 1.8× 174 1.5× 171 3.1× 29 0.8× 51 1.5× 6 442
Anchit Bhagat United States 7 132 0.6× 18 0.2× 75 1.3× 13 0.4× 38 1.1× 9 252

Countries citing papers authored by Manuel Lobo

Since Specialization
Citations

This map shows the geographic impact of Manuel Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Lobo more than expected).

Fields of papers citing papers by Manuel Lobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Lobo. The network helps show where Manuel Lobo may publish in the future.

Co-authorship network of co-authors of Manuel Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Lobo. A scholar is included among the top collaborators of Manuel Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Lobo. Manuel Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nuche, Jorge, et al.. (2022). Efecto cardioprotector del bloqueador beta de acción ultracorta esmolol en isquemia/reperfusión experimental. Revista Española de Cardiología. 75(6). 527–529. 1 indexed citations
2.
Galán‐Arriola, Carlos, Jean Paul Vilchez‐Tschischke, Manuel Lobo, et al.. (2021). Coronary microcirculation damage in anthracycline cardiotoxicity. Cardiovascular Research. 118(2). 531–541. 43 indexed citations
3.
Martínez‐Milla, Juan, Carlos Galán‐Arriola, Manuel Carnero, et al.. (2020). Translational large animal model of hibernating myocardium: characterization by serial multimodal imaging. Basic Research in Cardiology. 115(3). 33–33. 12 indexed citations
4.
Galán‐Arriola, Carlos, Rocío Villena-Gutiérrez, Gonzalo Pizarro, et al.. (2020). Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity. Cardiovascular Research. 117(4). 1132–1143. 38 indexed citations
5.
Galán‐Arriola, Carlos, Manuel Lobo, Jean Paul Vilchez‐Tschischke, et al.. (2019). Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity. Journal of the American College of Cardiology. 73(7). 779–791. 154 indexed citations
6.
Sánchez‐Gonzalez, Javier, Jaume Agüero, Rodrigo Fernández‐Jiménez, et al.. (2017). P567Early diagnosis of anthracycline induced cardiotoxicity in a swine model by serial multiparametric cardiac magnetic resonance. European Heart Journal. 38(suppl_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026